Skip to main content
Premium Trial:

Request an Annual Quote

Hint: It's Good to be a Merck Manager

The Wall Street Journal Health Blog reports that many top people at Merck will keep their positions as the merger with Schering-Plough goes through. Merck's CEO, Dick Clark, will stay in charge. Also keeping their spots are Kenneth Frazier, the head of global human health, Peter Kim, the head of research labs, and Willie Deese, the head of manufacturing. Schering-Plough's Stanley Barshay will continue to run the consumer health division, but only on an interim basis.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.